Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 84,000 shares at $20.87 ($1.7M) on 2023-01-18, disclosed to the SEC on 2023-01-19.
Open-market sale of $1.7M RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.23 | 28,000 | $566K | 33.1% |
| 2 | $20.87 | 28,000 | $584K | 34.1% |
| 3 | $20.02 | 28,000 | $561K | 32.8% |
| Total | $20.37 avg | 84,000 | $1.7M | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |